Benitec Biopharma Inc. (BNTC) EBITDA
- 2026-03-31: Basis Reported; EBITDA -$13.57M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$13.36M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$9.79M; Operating income (m); Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA -$9.82M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2019-06-30 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-03-31 | Reported | -$13.57M | (m) | (m) | (m) | (m) | $15.00K* | -$4.45M* | (m) | $6.30M | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$13.36M | (m) | (m) | (m) | (m) | (m) | -$3.78M* | (m) | $5.83M | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$9.79M | (m) | (m) | (m) | (m) | (m) | -$3.35M | (m) | $3.37M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$9.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.87M | (m) | (m) |
|---|
| 2025-03-31 | Reported | -$15.32M | (m) | (m) | (m) | (m) | $6.00K* | -$3.09M* | (m) | $6.50M | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$10.79M | (m) | (m) | (m) | (m) | (m) | -$7.70M* | (m) | $5.38M | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$5.77M | (m) | (m) | (m) | (m) | (m) | -$4.59M | (m) | $3.58M | (m) | (m) |
|---|
| 2024-06-30 | Reported | -$5.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-03-31 | Reported | -$4.12M | (m) | (m) | (m) | (m) | (m) | -$6.17M* | (m) | $2.57M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$6.91M | (m) | (m) | (m) | (m) | (m) | -$5.37M* | (m) | $5.10M | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$5.86M | (m) | (m) | (m) | (m) | (m) | -$4.58M | (m) | $4.43M | (m) | (m) |
|---|
| 2023-06-30 | Reported | -$4.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-03-31 | Reported | -$4.31M | (m) | (m) | $54,000.00 | -7979.63% | (m) | -$4.03M* | (m) | $3.17M | (m) | (m) |
|---|
| 2022-12-31 | Reported | -$5.57M | (m) | (m) | $14,000.00 | -39778.57% | (m) | -$5.84M* | (m) | $3.76M | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$4.54M | (m) | (m) | (m) | (m) | (m) | -$4.04M | (m) | $2.66M | (m) | (m) |
|---|
| 2022-06-30 | Reported | -$4.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-03-31 | Reported | -$3.41M | (m) | (m) | $48,000.00 | -7095.83% | $0.00* | -$3.42M* | (m) | $2.17M | (m) | (m) |
|---|
| 2021-12-31 | Reported | -$4.78M | (m) | (m) | $25,000.00 | -19120.00% | $0.00* | -$3.34M* | (m) | $3.15M | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$4.77M | (m) | (m) | (m) | (m) | $0.00 | -$4.28M | (m) | $2.78M | (m) | (m) |
|---|
| 2021-06-30 | Reported | -$3.8M | (m) | (m) | $2,000.00 | -190150.00% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-03-31 | Reported | -$3.73M | (m) | (m) | $1,000.00 | -372600.00% | $15.00K* | -$1.99M* | (m) | $2.76M | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$3.19M | (m) | (m) | $1,000.00 | -319200.00% | $174.00K* | -$3.33M* | (m) | $1.17M | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$2.65M | (m) | (m) | $55,000.00 | -4809.09% | $173.00K | -$2.36M | (m) | $774.00K | (m) | (m) |
|---|
| 2020-06-30 | Reported | -$2.85M | (m) | (m) | -$35,000.00 | 8134.29% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-03-31 | Reported | -$2.06M | (m) | (m) | $28,000.00 | -7367.86% | $0.00* | -$769.00K* | (m) | $805.00K | (m) | (m) |
|---|
| 2019-12-31 | Reported | -$2.06M | (m) | (m) | $77,000.00 | -2675.32% | (m) | -$3.08M* | (m) | $599.00K | (m) | (m) |
|---|
| 2019-09-30 | Reported | -$1.12M | (m) | (m) | $33,000.00 | -3378.79% | (m) | -$545.00K | (m) | $423.00K | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$51.13M* | -$51.19M | $58.00K | (m) | (m) | $105.00K | -$16.52M | (m) | $23.39M | (m) | $0.00 |
|---|
| 2026-03-31 | Rolling | (m) | -$46.60M* | (m) | (m) | (m) | (m) | (m) | (m) | $18.37M* | (m) | (m) |
|---|
| 2025-12-31 | Rolling | (m) | -$48.35M* | (m) | (m) | (m) | (m) | (m) | (m) | $18.57M* | (m) | (m) |
|---|
| 2025-09-30 | Rolling | (m) | -$45.78M* | (m) | (m) | (m) | (m) | (m) | (m) | $18.12M* | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$41.7M | (m) | (m) | (m) | (m) | $18.00K | -$23.59M | (m) | $18.33M | (m) | (m) |
|---|
| 2025-06-30 | Rolling | (m) | -$41.77M* | (m) | (m) | (m) | (m) | (m) | (m) | $18.33M* | (m) | (m) |
|---|
| 2024-06-30 | Reported | -$22.4M | (m) | (m) | (m) | (m) | $179.00K | -$19.40M | (m) | $15.61M | (m) | (m) |
|---|
| 2023-06-30 | Reported | -$18.95M | (m) | (m) | $75,000.00 | -25260.00% | $1.00K | -$18.01M | (m) | $12.77M | (m) | (m) |
|---|
| 2022-06-30 | Reported | -$17.69M | (m) | (m) | $73,000.00 | -24228.77% | $13.00K | -$15.90M | (m) | $11.27M | (m) | (m) |
|---|
| 2021-06-30 | Reported | -$13.37M | (m) | (m) | $59,000.00 | -22652.54% | $221.00K | -$12.83M | (m) | $7.02M | (m) | (m) |
|---|
| 2020-06-30 | Reported | -$8.09M | (m) | (m) | $97,000.00 | -8341.24% | $95.00K | -$7.54M | (m) | $3.00M | (m) | (m) |
|---|
| 2019-06-30 | Reported | $2.74M | (m) | (m) | $11.55M | 23.73% | $404.00K | $4.79M | (m) | $4.57M | (m) | (m) |
|---|